Aspiriant LLC’s Schwab Fundamental US Large Company Index ETF FNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$228K Hold
8,199
0.01% 316
2025
Q4
$223K Hold
8,199
0.01% 309
2025
Q3
$216K Sell
8,199
-783
-9% -$19.9K 0.01% 288
2025
Q2
$220K Hold
8,982
0.01% 293
2025
Q1
$212K Hold
8,982
0.01% 281
2024
Q4
$213K Hold
8,982
0.01% 278
2024
Q3
$215K Buy
+8,982
New +$207K 0.01% 272
2018
Q4
Sell
-18,525
Closed -$245K 235
2018
Q3
$245K Hold
18,525
0.02% 212
2018
Q2
$231K Sell
18,525
-10,860
-37% -$135K 0.02% 227
2018
Q1
$356K Buy
+29,385
New +$370K 0.03% 176

Other funds holding FNDX

Aspiriant LLC's FNDX Position: Q1 2026 in Review

Aspiriant LLC held its Schwab Fundamental US Large Company Index ETF (FNDX) position steady in Q1 2026 at 8,199 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #316.

Aspiriant LLC first reported a position in FNDX in Q1 2018 and has held it in 10 quarters since. The position peaked at $356K in Q1 2018. 776 funds tracked by Wall St. Rank hold FNDX as of Q1 2026.

  • Aspiriant LLC held 8,199 shares of Schwab Fundamental US Large Company Index ETF worth $228K as of Q1 2026.
  • Aspiriant LLC left its Schwab Fundamental US Large Company Index ETF share count unchanged in Q1 2026.
  • Schwab Fundamental US Large Company Index ETF made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #316 holding.
  • Aspiriant LLC first reported a position in Schwab Fundamental US Large Company Index ETF in Q1 2018 and has held it in 10 quarters since.
  • Aspiriant LLC's Schwab Fundamental US Large Company Index ETF position peaked at $356K in Q1 2018.
  • 776 funds tracked by Wall St. Rank held Schwab Fundamental US Large Company Index ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.